litlas
Log inCreate account

Hiroshi Yoshida

Active 1969–2026

375
Papers
23,304
Citations
84
h-index
253
i10-index

Citations

Citations per year for Hiroshi Yoshida1964: 1 citations1969: 2 citations1970: 1 citations1972: 1 citations1974: 5 citations1975: 1 citations1976: 3 citations1978: 1 citations1979: 2 citations1980: 14 citations1981: 9 citations1982: 10 citations1983: 7 citations1984: 2 citations1985: 2 citations1986: 6 citations1987: 8 citations1988: 12 citations1989: 16 citations1990: 14 citations1991: 10 citations1992: 10 citations1993: 12 citations1994: 11 citations1995: 15 citations1996: 21 citations1997: 25 citations1998: 25 citations1999: 59 citations2000: 61 citations2001: 67 citations2002: 63 citations2003: 94 citations2004: 92 citations2005: 109 citations2006: 98 citations2007: 115 citations2008: 140 citations2009: 167 citations2010: 199 citations2011: 205 citations2012: 197 citations2013: 172 citations2014: 172 citations2015: 173 citations2016: 157 citations2017: 168 citations2018: 155 citations2019: 529 citations2020: 618 citations2021: 676 citations2022: 573 citations2023: 494 citations2024: 783 citations2025: 418 citations2026: 17 citations1965–1968: no citations, so these years are not shown1971: no citations, so this year is not shown1973: no citations, so this year is not shown1977: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,963 citing papers, 20% of this breakdownJapan: 1,394 citing papers, 14.2% of this breakdownChina: 1,288 citing papers, 13.1% of this breakdownUnited Kingdom: 486 citing papers, 5% of this breakdownItaly: 387 citing papers, 3.9% of this breakdownGermany: 372 citing papers, 3.8% of this breakdownSouth Korea: 285 citing papers, 2.9% of this breakdownCanada: 253 citing papers, 2.6% of this breakdownFrance: 221 citing papers, 2.3% of this breakdownSpain: 198 citing papers, 2% of this breakdownIndia: 198 citing papers, 2% of this breakdownAustralia: 175 citing papers, 1.8% of this breakdown
0%20%Other 26.4%

Institutions

Fields

  • Medicine54%
  • Biochemistry, Genetics and Molecular Biology20.1%
  • Engineering7.3%
  • Computer Science4.3%
  • Immunology and Microbiology3.2%
  • Neuroscience2.5%
  • Other8.6%

Topics

  • Autophagy in Disease and Therapy4.2%
  • Endoplasmic Reticulum Stress and Disease1.4%
  • Antioxidant Activity and Oxidative Stress1.3%
  • Cholangiocarcinoma and Gallbladder Cancer Studies1.1%
  • Cancer Immunotherapy and Biomarkers1.1%
  • Cancer Genomics and Diagnostics1%
  • Other89.9%

Coauthors

All papers

Open in search
  1. CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory

    Authors: Yujiro Kidani, Wataru Nogami, Yoshiaki Yasumizu, Atsunari Kawashima, Atsushi Tanaka, Yudai Sonoda, Yumi Tona, Kunitaka Nashiki, Reimi Matsumoto, Masaki Hagiwara, Motonao Osaki, Keiji Dohi, Takayuki Kanazawa, Azumi Ueyama, Mai Yoshikawa, Tetsuya Yoshida, Mitsunobu Matsumoto, Kanji Hojo, Satomi Shinonome, Hiroshi Yoshida, Michinari Hirata, Miya Haruna, Yamami Nakamura, Daisuke Motooka, Daisuke Okuzaki, Yasuko Sugiyama, Makoto Kinoshita, Tatsusada Okuno, Taigo Kato, Koji Hatano, Motohide Uemura, Ryoichi Imamura, Kazunori Yokoi, Atsushi Tanemura, Yasushi Shintani, Tadashi Kimura, Norio Nonomura, Hisashi Wada, Masaki Mori, Yuichiro� Doki, Naganari Ohkura, Shimon Sakaguchi - National Academy of Sciences, Proceedings of the National Academy of Sciences 2022 cited by 204

  2. Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice

    Authors: Masaaki Komatsu, Satoshi Waguri, Masato Koike, Yu‐shin Sou, Takashi Ueno, Taichi Hara, Noboru Mizushima, J. Iwata, Junji Ezaki, Shigeo Murata, Jun Hamazaki, Yasumasa Nishito, Shun-ichiro Iemura, Tohru Natsume, Toru Yanagawa, Junya Uwayama, Eiji Warabi, Hiroshi Yoshida, Tetsuro Ishii, Akira Kobayashi, Masayuki Yamamoto, Zhenyu Yue, Yasuo Uchiyama, Eiki Kominami, Keiji Tanaka - Cell 2007 cited by 2,129

  3. Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers

    Authors: Hideaki Ogiwara, Kazuaki Takahashi, Mariko Sasaki, Takafumi Kuroda, Hiroshi Yoshida, Reiko Watanabe, Ami Maruyama, Hideki Makinoshima, Fumiko Chiwaki, Hiroki Sasaki, Tomoyasu Kato, Aikou Okamoto, Takashi Kohno - Cancer Cell 2019 cited by 296

  4. Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2–Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial

    Authors: Tadaaki Nishikawa, Kosei Hasegawa, Koji Matsumoto, Masahiko Mori, Yasuyuki Hirashima, Kazuhiro Takehara, Kazuya Ariyoshi, Tomoyasu Kato, Shigehiro Yagishita, Akinobu Hamada, Mamiko Kawasaki, Satoshi Kawashima, Sawako Tomatsuri, Yukari Nagasaka, Hiroshi Yoshida, Ryunosuke Machida, Akihiro Hirakawa, Kenichi Nakamura, Kan Yonemori - Journal of Clinical Oncology 2023 cited by 127

  5. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

    Authors: Tomonori Okamura, Kazuhisa Tsukamoto, Hidenori Arai, Yoshio Fujioka, Yasushi Ishigaki, Shinji Koba, Hirotoshi Ohmura, Tetsuo Shoji, Koutaro Yokote, Hiroshi Yoshida, Masayuki Yoshida, Juno Deguchi, Kazushige Dobashi, Akira Fujiyoshi, Hirotoshi Hamaguchi, Masumi Hara, Mariko Harada‐Shiba, Takumi Hirata, Mami Iida, Yoshiyuki Ikeda, Shun Ishibashi, Hideyuki Kanda, Shinji Kihara, Kazuo Kitagawa, Satoru Kodama, Masahiro Koseki, Yoshiro Maezawa, Daisaku Masuda, Takashi Miida, Yoshihiro Miyamoto, Rimei Nishimura, Koichi Node, Midori Noguchi, Mitsuru Ohishi, Isao Saito, Shojiro Sawada, Hirohito Sone, Minoru Takemoto, Akihiko Wakatsuki, Hidekatsu Yanai - Journal of Atherosclerosis and Thrombosis 2023 cited by 269

  6. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

    Authors: Makoto Kinoshita, Koutaro Yokote, Hidenori Arai, Mami Iida, Yasushi Ishigaki, Shun Ishibashi, Seiji Umemoto, Genshi Egusa, Hirotoshi Ohmura, Tomonori Okamura, Shinji Kihara, Shinji Koba, Isao Saito, Tetsuo Shoji, Hiroyuki Daida, Kazuhisa Tsukamoto, Juno Deguchi, Seitaro Dohi, Kazushige Dobashi, Hirotoshi Hamaguchi, Masumi Hara, Takafumi Hiro, Sadatoshi Biro, Yoshio Fujioka, Chizuko Maruyama, Yoshihiro Miyamoto, Yoshitaka Murakami, Masayuki Yokode, Hiroshi Yoshida, Hiromi Rakugi, Akihiko Wakatsuki, Shizuya Yamashita - Journal of Atherosclerosis and Thrombosis 2018 cited by 822

  7. Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives

    Authors: Hidekatsu Yanai, Hiroshi Yoshida - International Journal of Molecular Sciences 2019 cited by 481

  8. Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study

    Authors: Kuniko Sunami, Hitoshi Ichikawa, Takashi Kubo, Mamoru Kato, Yutaka Fujiwara, Akihiko Shimomura, Takafumi Koyama, Hiroki Kakishima, Mayuko Kitami, Hiromichi Matsushita, Eisaku Furukawa, Daichi Narushima, Momoko Nagai, Hirokazu Taniguchi, Noriko Motoi, Shigeki Sekine, Akiko Miyagi Maeshima, Taisuke Mori, Reiko Watanabe, Masayuki Yoshida, Akihiko Yoshida, Hiroshi Yoshida, Kaishi Satomi, Aoi Sukeda, Taiki Hashimoto, Toshio Shimizu, Satoru Iwasa, Kan Yonemori, Ken Kato, Chigusa Morizane, Chitose Ogawa, Noriko Tanabe, Kokichi Sugano, Nobuyoshi Hiraoka, Kenji Tamura, Teruhiko Yoshida, Yasuhiro Fujiwara, Atsushi Ochiai, Noboru Yamamoto, Takashi Kohno - Cancer Science 2019 cited by 377

  9. Trastuzumab deruxtecan (T-DXd; DS-8201) in patients (pts) with HER2-expressing unresectable or recurrent biliary tract cancer (BTC): An investigator-initiated multicenter phase 2 study (HERB trial).

    Authors: Akihiro Ohba, Chigusa Morizane, Yasuyuki Kawamoto, Yoshito Komatsu, Makoto Ueno, Satoshi Kobayashi, Masafumi Ikeda, Mitsuhito Sasaki, Junji Furuse, Naohiro Okano, Nobuyoshi Hiraoka, Hiroshi Yoshida, Aya Kuchiba, Ryo Sadachi, Kenichi Nakamura, Naoko Matsui, Yoshiaki Nakamura, Wataru Okamoto, Takayuki Yoshino, Takuji Okusaka - Journal of Clinical Oncology 2022 cited by 107

  10. Lactate-induced histone lactylation by p300 promotes osteoblast differentiation

    Authors: Erika Minami, Kiyohito Sasa, Atsushi Yamada, Ryota Kawai, Hiroshi Yoshida, Haruhisa Nakano, Koutaro Maki, Ryutaro Kamijo - PLoS ONE 2023 cited by 59

  11. Potential Anti-Atherosclerotic Properties of Astaxanthin

    Authors: Yoshimi Kishimoto, Hiroshi Yoshida, Kazuo Kondo - Marine Drugs 2016 cited by 221

  12. The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer

    Authors: Miya Haruna, Azumi Ueyama, Yoko Yamamoto, Michinari Hirata, Kumiko Goto, Hiroshi Yoshida, Naoko Higuchi, Tetsuya Yoshida, Yujiro Kidani, Yamami Nakamura, Morio Nagira, Atsunari Kawashima, Kota Iwahori, Yasushi Shintani, Naganari Ohkura, Hisashi Wada - Scientific Reports 2022 cited by 65

  13. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia

    Authors: Hiroshi Yoshida, Hidekatsu Yanai, Kumie Ito, Yoshiharu Tomono, Takashi Koikeda, Hiroki Tsukahara, Norio Tada - Atherosclerosis 2009 cited by 265

  14. Utility of the revised FIGO2023 staging with molecular classification in endometrial cancer

    Authors: Mayumi Kobayashi-Kato, Erisa Fujii, Yuka Asami, Yuka Ahiko, Kengo Hiranuma, Yasuhisa Terao, Koji Matsumoto, Mitsuya Ishikawa, Takashi Kohno, Tomoyasu Kato, Kouya Shiraishi, Hiroshi Yoshida - Gynecologic Oncology 2023 cited by 42

  15. Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data

    Authors: Paul A. Cohen, Aime Powell, Steffen Böhm, C. Blake Gilks, Colin J.R. Stewart, Tarek Meniawy, Max Bulsara, Stefanie Avril, Eleanor C. Brockbank, Tjalling Bosse, Gustavo Rubino de Azevedo Focchi, Raji Ganesan, Rosalind Glasspool, Brooke E. Howitt, Hyun Soo Kim, Jung‐Yun Lee, Nhu D. Le, Michelle Lockley, Ranjit Manchanda, Trupti Mandalia, W. Glenn McCluggage, Iain A. McNeish, Divya Midha, Radhika Srinivasan, Yun Yi Tan, Rachael van der Griend, Mayu Yunokawa, Gian Franco Zannoni, Naveena Singh, Simi Aggarwal, Holger Bronger, Elizabeth Brown, Martin Buck, Syed Abdullah Javaid Bukhari, Edwina Coghlan, Nichola Cope, Michelle Samora de Almeida, Cor D. de Kroon, Andrew Dean, Michael-John Devlin, Helena Møgelbjerg Ditzel, Enken Drecoll, Takahiro Ebata, Anna Fagotti, Asma Faruqi, Laura Feeney, Kavita Gupta, Ian Harley, Frediano Inzani, Arjun Jeyarajah, Mei Hui Eleanor Koay, Judith R. Kroep, Jung‐Yun Lee, Yee Leung, Michelle Lockley, Alice R. Loft, Daniel Magee, Ranjit Manchanda, Sarah McKenna, Divya Midha, David Millan, Joanne Millar, Rowan Miller, Ganendra Raj Mohan, Sohail Mughal, Asima Mukhopadhyay, Sérgio Mancini Nicolau, James Nevin, Abigail S. Oakley, Mary Quigley, Bhavana Rai, Arvind Rajwanshi, Stuart Salfinger, Giovanni Scambia, Kate Scatchard, Barbara Schmalfeldt, Bryony Simcock, Priya Singh, Kyle C. Strickland, Vainta Suri, Sheeba Syed, Peter Sykes, Kenji Tamura, Adeline Tan, Jason Tan, Emily F. Thompson, Anna V. Tinker, Georgia Trevisan, Maria Gabriela Baumgarten Kuster Uyeda, Michelle Vaughan, Wilko Weichert, Anthony T. Williams, Sarah Williams, Hiroshi Yoshida, Pier Carlo Zorzato - Gynecologic Oncology 2019 cited by 121

  16. Multicenter phase II trial of trastuzumab deruxtecan for HER2-positive unresectable or recurrent biliary tract cancer: HERB trial

    Authors: Akihiro Ohba, Chigusa Morizane, Makoto Ueno, Satoshi Kobayashi, Yasuyuki Kawamoto, Yoshito Komatsu, Masafumi Ikeda, Mitsuhito Sasaki, Naohiro Okano, Junji Furuse, Nobuyoshi Hiraoka, Hiroshi Yoshida, Aya Kuchiba, Ryo Sadachi, Kenichi Nakamura, Naoko Matsui, Yoshiaki Nakamura, Wataru Okamoto, Takayuki Yoshino, Takuji Okusaka - Future Oncology 2022 cited by 67

  17. Safe and Efficient Dynamic Window Approach for Differential Mobile Robots With Stochastic Dynamics Using Deterministic Sampling

    Authors: Shinya Yasuda, Taichi Kumagai, Hiroshi Yoshida - IEEE Robotics and Automation Letters, IEEE Robotics Autom. Lett. 2023 cited by 23

  18. Details of human epidermal growth factor receptor 2 status in 454 cases of biliary tract cancer

    Authors: Nobuyoshi Hiraoka, Hiroaki Nitta, Akihiro Ohba, Hiroshi Yoshida, Chigusa Morizane, Takuji Okusaka, Satoshi Nara, Minoru Esaki, Yoji Kishi, Kazuaki Shimada - Human Pathology 2020 cited by 43

  19. Targeting PDGF signaling of cancer-associated fibroblasts blocks feedback activation of HIF-1α and tumor progression of clear cell ovarian cancer

    Authors: Yutaro Mori, Y Okimoto, Hiroaki Sakai, Yusuke Kanda, Hirokazu Ohata, Daisuke Shiokawa, Mikiko Suzuki, Hiroshi Yoshida, Haruka Ueda, Tomoyuki Sekizuka, Ryo Tamura, Kaoru Yamawaki, Tatsuya Ishiguro, Raúl Nicolás Mateos, Yuichi Shiraishi, Yasushi Yatabe, Akinobu Hamada, Kosuke Yoshihara, Takayuki Enomoto, Koji Okamoto - Cell Reports Medicine 2024 cited by 38

  20. Methylation status and long‐fragment cell‐free DNA are prognostic biomarkers for gastric cancer

    Authors: Kazuhide Ko, Yoshikazu Kananazawa, Takeshi Yamada, Daisuke Kakinuma, K. Matsuno, Fumihiko Ando, Sho Kuriyama, Akihisa Matsuda, Hiroshi Yoshida - Cancer Medicine 2021 cited by 38

  21. A 950-MHz rectifier circuit for sensor network tags with 10-m distance

    Authors: Toshiyuki Umeda, Hiroshi Yoshida, Shuichi Sekine, Yumi Fujita, Takuji Suzuki, Shoji Otaka - IEEE Journal of Solid-State Circuits, IEEE J. Solid State Circuits 2005 cited by 419

  22. Mechanisms of LDL oxidation

    Authors: Hiroshi Yoshida, Reiko Kisugi - Clinica Chimica Acta 2010 cited by 284

  23. Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2–Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial

    Authors: Akihiro Ohba, Chigusa Morizane, Yasuyuki Kawamoto, Yoshito Komatsu, Makoto Ueno, Satoshi Kobayashi, Masafumi Ikeda, Mitsuhito Sasaki, Junji Furuse, Naohiro Okano, Nobuyoshi Hiraoka, Hiroshi Yoshida, Aya Kuchiba, Ryo Sadachi, Kenichi Nakamura, Naoko Matsui, Yoshiaki Nakamura, Wataru Okamoto, Takayuki Yoshino, Takuji Okusaka - Journal of Clinical Oncology 2024 cited by 50

  24. Secondary dyslipidemia: its treatments and association with atherosclerosis

    Authors: Hidekatsu Yanai, Hiroshi Yoshida - Global Health & Medicine 2020 cited by 67